Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted…
Author: Scott Matusow
$SSH Analyst Opinion Excerpts (Premium Content)
Oppenheimer Excerpt: “■ Meaningful market opportunity. We estimate SSH’s target market potential in the more severe Class III/ambulatory Class IV heart failure patient population at ~$7.5B in the US alone. The Affordable Care Act incentivizes hospitals to reduce HF re-hospitalizations,…
Video: Charts and Commentary For 10/20/13 (Premium Content)
Charts and Commentary For 10/20/13. $ATRS $HALO $SSH $ENTA $CLDX $ACAD are covered along with some additional commentary on ATRS, ENTA, CLDX, ACAD, and SSH. Enjoy! Scott
Our New Catalyst Trade and investment pick – Enanta (ENTA)
Our New Catalyst Trade and investment pick – Enanta (ENTA). Excerpt from our article written by Kyle Dennis below: Enanta Pharmaceuticals (ENTA) is a biotechnology company that focuses on the development of small molecules to treat infectious diseases. The company…
Video: Market Commentary for 10/15/13 (Premium Content)
Scott’s Market Commentary for 10/15/13 (Premium Content). Dow and S&P 500 charts analyzed, $ATRS explained, Debt ceiling, catalyst trading psychology, understanding the catalyst trade and what drives it, plus my views on the current “situation” we face from the morons in…
$HALO Trade Alert: Price target Opinion raised to $12 conditional on Debt Ceiling agreement
$BSX plans to announce update on $HALO CC w HyQ News = re FDA Refiling, Launch Details from Germany and Scandanavia We feel these catalysts should move stock price over $12 by end of month $BSX catalyst date is October 17th, while…
Video: Market Forecast and Commentary for Upcoming Week 10/14/13 (Premium Content)
Market Forecast and Commentary for Upcoming Week 10/14/13. $ATRS, $HALO, $ACRX, $SLTM covered. Debt Ceiling fiasco covered. Possible outcomes, etc, etc. Scott
Market and Political Commentary For Friday, 10/10/13 (Premium Content)
Market and Political Commentary For Friday, 10/10/13. $HALO $ACRX $ATRS. I Give my views on the current political situation we are facing now along with market commentary and why spec stocks go down under a “risk off” environment. Enjoy and…
We bought $HALO – Some additional Information on it
Halozyme (HALO) has a potential breakthrough in new therapeutic combination represents how pancreatic cancer has evaded standard treatments for patients. On September 30th, the company announced mature patient progression free survival (PFS) and ongoing overall survival (OS) data from its…
Video:Market Update Charts and Commentary for 10/10/13 (Premium Content)
Market Update, Charts and Commentary for 10/10/13 (Premium Content) $HALO $ATRS $ACRX Markets likely to rally thru Friday into 4 day Weekend as debt ceiling and gov shut down deal looks more likely to be in place over the weekend.…
